Modulation of NLGn4 expression, NK cell activity in non-alcoholic fatty liver disease (NAFLD)

• 收藏
• 分享

专利权人:

发明人:

Rifaat Safadi

申请号：

US14963319

公开号：

US09469855B2

申请日:

2015.12.09

申请国别(地区):

US

年份:

2016

代理人:

摘要：

The present invention provides a method of treating, attenuating or preventing a liver disorder by inhibiting NGn4 expression and thereby modulating the activity of NK cells. The present invention further relates to diagnosing a liver disorder by evaluating NLGn4 expression in NK cells.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/